Platform for a Technological Leap in Antibiotics.
Journal: 2016/February - Chimia
ISSN: 0009-4293
Abstract:
NTN Swiss Biotech™ brings together the Swiss Biotech Association SBA, which is involved in regulatory, financial and legal issues, and biotechnet Switzerland, which is active in translational R&D, to provide a technology base for joint projects. Biotechnet aims to push promising domains by creating topic-oriented platforms that enable academia and industry to work together to produce R&D results of major importance to society and the economy. The first activity initiated by biotechnet is the Antibiotics Platform that has now been launched.
Relations:
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.